 Hyundai Motor IndiaPassenger Cars & Utility Vehicles | Q1 FY27 results: PAT falls 34% YoY, dividend record date Aug 530 Jul 2026Revenue DeclinePat NegativeEbitda Margin Compression | +9.4% +11.6% — | ₹2,219 | 1.80 L Cr | 34.0vs 25.5 | 32.2% | +8.3% |
 Granules IndiaPharmaceuticals | Board approves Q1 FY27 results with mixed performance21 Jul 2026Revenue DeclinePat NegativeEbitda Margin Compression | -3.2% -5.2% — | ₹860 | 21,311 Cr | 29.8vs 28.5 | 13.9% | +13.4% |
 Glenmark PharmaceuticalsPharmaceuticals | The Board of Directors of Glenmark Pharmaceuticals Limited considered and approved audited financial results and recommended dividend.29 May 2026Pat NegativeRevenue DeclineEbitda Margin Compression | -5.0% -6.4% -6.0% | ₹2,318 | 65,411 Cr | 46.4vs 28.5 | 14.7% | -37.6% |
 Oil And Natural Gas Corp.Oil Exploration & Production | Oil & Natural Gas Corporation Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.26 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | -7.5% -7.9% -18.6% | ₹236 | 2.97 L Cr | 7.1vs 42.5 | 10.4% | +10.1% |
 Sun Pharmaceutical Ind LPharmaceuticals | Sun Pharmaceutical Industries Limited has informed the Exchange about Financial Results and Recommendation of Dividend for FY 2025-2622 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -2.3% -5.3% -1.2% | ₹1,902 | 4.56 L Cr | 37.6vs 28.5 | 17.5% | +0.9% |
 Navigant Corporate Advisors LiOther Financial Services | With reference to the above captioned subject, we wish to intimate your esteemed exchange that as decided in the Meeting of the Board of Directors of the Company held on Thursday, May 21, ....21 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | pending | ₹72.92 | 2.30 L Cr | 9.0vs 16.7 | 9.7% | -42.1% |
 PI IndustriesPesticides & Agrochemicals | PI Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.19 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -11.8% -13.2% -10.0% | ₹2,497 | 37,951 Cr | 37.0vs 25.0 | 14.5% | -16.4% |
 Cochin ShipyardShip Building & Allied Services | Please refer attachment15 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -6.7% -4.2% -7.9% | ₹1,481 | 38,949 Cr | 57.8 | 15.3% | +32.7% |
 Deepak NitriteSpecialty Chemicals | Financial Results for the year ended 31st March, 202615 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | -0.8% -5.2% -8.4% | ₹1,740 | 23,734 Cr | 37.1vs 30.0 | 10.2% | +11.5% |
 Tata Motors Pass VehPassenger Cars & Utility Vehicles | Tata Motors Passenger Vehicles Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.14 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | +4.4% +14.1% +17.3% | ₹318 | 1.17 L Cr | 25.5vs 25.5 | -1.0% | +45.8% |
 Oil IndiaOil Exploration & Production | Oil India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.13 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | +2.7% -4.4% -17.3% | ₹475 | 77,264 Cr | 11.7vs 42.5 | 7.9% | +9.1% |
 DR. Reddy S LaboratoriesPharmaceuticals | Audited Financial Results for the year ended March 31, 202612 May 2026Revenue DeclinePat NegativeEbitda Margin Compression | +2.7% +3.4% +0.9% | ₹1,175 | 98,087 Cr | 34.2vs 28.5 | 13.0% | -14.5% |
 Godrej PropertiesResidential Commercial Projects | Godrej Properties Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.4 May 2026Revenue DeclinePat NegativeEbitda Margin Compression×2 | -1.1% -5.7% -7.5% | ₹2,035 | 61,294 Cr | 36.3vs 22.3 | 11.4% | +367.1% |
 Piramal PharmaPharmaceuticals | Piramal Pharma FY26: Revenue Down 3%, Posts ₹326 Cr Loss on Impairment28 Apr 2026Revenue DeclineEbitda Margin CompressionPat Negative | -1.7% +11.6% +4.9% | ₹213 | 28,302 Cr | — | -1.8% | +34.6% |
 Angel OneStockbroking & Allied | Angel One Limited has informed the Exchange about General Updates16 Apr 2026Pat NegativeEbitda Margin CompressionRevenue Decline | +8.7% +8.9% +3.7% | ₹288 | 26,215 Cr | 4.3vs 15.8 | — | +21.4% |
